Puma Biotechnology share price logo

Puma Biotechnology

NASDAQ: PBYI

Small Cap

$10.92

+0.16

(+1.49%)

Live

as on

Puma Biotechnology Stock Performance

as on October 22, 2026 at 6:09 am IST

  • Day's Low

    Day's High

    $10.61
    $10.98
    downward going graph

    2.84%

    Downside

    0.55%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.58
    $10.72
    downward going graph

    58.10%

    Downside

    -1.83%

    Upside

    downward going graph

Puma Biotechnology share price movements today

Previous Close
$10.76
Open
$10.74
Volume
258.7K
Market Cap
$507.4M
Day's Low - High
$10.61 - $10.98
52 Week Low - High
$4.58 - $10.72

Puma Biotechnology Historical Returns

1 Month Return
+ 6.35 %
3 Month Return
+ 23.01 %
1 Year Return
+ 87.34 %
3 Year Return
+ 343.91 %
5 Year Return
+ 72.76 %

Puma Biotechnology Stock Fundamentals & Key Indicators

Check Puma Biotechnology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$507.4M

EPS (TTM)

0.5362

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.36%

PE Ratio (TTM)

18.33

Industry PE ratio

-7.03

PEG Ratio

-0.41

EBITDA

45.2M

Revenue (TTM)

231.2M

Profit Margin

74.83%

Return On Equity TTM

20.85%

Puma Biotechnology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Puma Biotechnology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$507.4M72.76%18.3374.83%0.00%
Neutral$87.0B-31.87%-27.32-12.57%0.00%
StrongBuy$126.7B170.61%28.8586.04%0.00%
Buy$81.4B38.98%18.8884.86%0.47%

Stock Returns calculator for Puma Biotechnology Stock including INR - Dollar returns

The Puma Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Puma Biotechnology investment value today

Current value as on today

₹2,15,002

Returns

₹1,15,002

(+115%)

Returns from Puma Biotechnology Stock

₹1,00,367 (+100.37%)

Dollar Impact

₹14,635 (+14.63%)

Analyst Recommendation on Puma Biotechnology Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'HOLD' rating for Puma Biotechnology. Average target price of $6

Puma Biotechnology Share Price Target

Get share price movements and forecasts by analysts on Puma Biotechnology.

What analysts predicted

-82%DOWNSIDE

Target Price

$6

Current Price

$10.92

Analyzed by

1 Analysts

High

$6

Target

$6.00

Low

$6

Puma Biotechnology target price $6, a slight downside of -82% compared to current price of $10.92. According to 1 analysts rating.

Indian Investors' Interest in Puma Biotechnology Stock

Search interest for Puma Biotechnology Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Puma Biotechnology Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
43
47
80
59
46
52
54
75
44
56
Gross Profit
33
36
51
45
35
40
42
52
34
44
Operating Income
-2
-2
22
13
3
6
9
17
-3
7
EBITDA
1
2
26
17
8
10
13
20
0
10
Interest Expense
3
3
3
2
2
1
1
1
0
0
Depreciation
2
2
2
2
2
2
2
2
2
2
Income Before Tax
-4
-4
20
12
3
6
9
17
-3
8
Income Tax Expense
0
0
0
-7
0
0
0
3
0
0
Net Income
-4
-4
20
19
2
5
8
13
-3
8
Net Profit Margin
75.49%
77.36%
63.87%
76.44%
77.06%
76.54%
77.65%
69.35%
76.74%
77.92%

Puma Biotechnology Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
27
251
272
225
253
228
235
230
228
Gross Profit
22
216
235
185
189
172
172
166
170
Operating Income
-292
-94
-75
-30
1
23
32
30
37
EBITDA
-288
-95
-52
-35
-4
21
47
48
53
Interest Expense
0
11
15
14
12
11
13
12
6
Depreciation
2
7
8
10
11
9
11
11
10
Income Before Tax
-292
-113
-75
-59
-28
0
22
24
35
Income Tax Expense
-2
-7
0
0
0
0
1
-6
4
Net Income
-292
-113
-75
-59
-29
0
21
30
31
Net Profit Margin
79.78%
86.22%
86.48%
82.51%
74.84%
75.84%
73.40%
72.06%
74.53%

Puma Biotechnology Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-4
20
19
2
5
8
13
-3
8
Operating Cash Flow
11
1
11
15
3
14
9
14
15
1
Investing Cash Flow
-19
0
0
-2
1
-11
0
-26
2
7
Financing Cash Flow
-
-11
-11
-11
-11
-11
-11
-11
-11
-11
Change in Cash
-7
-9
0
1
-6
-8
-1
-23
6
-1

Puma Biotechnology Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-291
-113
-75
-59
-29
0
21
30
31
Operating Cash Flow
-172
-24
22
0
20
-15
27
38
41
Investing Cash Flow
-15
-57
5
23
-10
7
-19
-20
-36
Financing Cash Flow
75
108
-67
0
-31
12
-
-33
-45
Change in Cash
-112
26
-39
24
-22
3
7
-15
-39

Global Institutional Holdings in Puma Biotechnology

Check out the Institutions with significant holdings in Puma Biotechnology.

Funds
Holdings
Avantis
5.20%
Vanguard
4.32%
iShares
3.60%
VANGUARD INDEX FUNDS
3.42%
DFA
1.92%

Insights on Puma Biotechnology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -3.75M → 8.18M (in $), with an average increase of 145.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PBYI stock has moved up by 12.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 44.81M → 56.50M (in $), with an average increase of 20.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PBYI has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 780.6% return, outperforming this stock by 672.5%

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.
OrganisationPuma Biotechnology
Headquarters10880 Wilshire Boulevard, Los Angeles, CA, 90024, US
IndustryBiotechnology
CEOAlan H. Auerbach

Key Management of Puma Biotechnology

Name

Title

Ms. Heather Blaber

Senior Vice President of Marketing

Ms. Pamela Wilson BA

Senior Vice President of Clinical Operations

Mr. Kenneth Wiehe

Senior Vice President of Supply Chain & Manufacturing

Mr. Douglas Hunt B.Sc., FRAPS

Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer

Mr. Gordon G. Esplin

Chief Accounting Officer

Mr. Mariann Ohanesian

Senior Director of Investor Relations

Mr. Roger L. Storms

Senior Vice President of Sales

Dr. Petra Rietschel

Senior Vice President of Clinical Development

Mr. Alan H. Auerbach

Founder, Chairman, President, CEO & Secretary

Mr. Maximo F. Nougues

CFO & Principal Accounting Officer

FAQs

What is Puma Biotechnology share price today?

Puma Biotechnology share price today is $10.92 as on . Puma Biotechnology share today touched a day high of $10.98 and a low of $10.61.

What is the 52 week high and 52 week low for Puma Biotechnology share?

Puma Biotechnology share touched a 52 week high of $10.72 on and a 52 week low of $4.58 on . Puma Biotechnology stock price today i.e. is trending at $10.92,which is -1.87% down from its 52 week high and 138.69% up from its 52 week low.

What is Puma Biotechnology's market capitalisation today?

Puma Biotechnology market capitalisation is $0.00T as on .

How to invest in Puma Biotechnology Stock (PBYI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Puma Biotechnology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Puma Biotechnology Stock (PBYI) from India?

Indian investors can start investing in Puma Biotechnology (PBYI) shares with as little as ₹94.449996948242 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.50 in Puma Biotechnology stock (as per the Rupee-Dollar exchange rate as on ). Based on Puma Biotechnology share’s latest price of $10.92 as on October 22, 2026 at 12:39 am IST, you will get 0.9158 shares of Puma Biotechnology. Learn more about fractional shares .

What are the returns that Puma Biotechnology has given to Indian investors in the last 5 years?

Puma Biotechnology stock has given 72.76% share price returns and 26.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?